Haematologica (Mar 2019)

Clinical implications of subclonal TP53 mutations in acute myeloid leukemia

  • Katharina T. Prochazka,
  • Gudrun Pregartner,
  • Frank G. Rücker,
  • Ellen Heitzer,
  • Gabriel Pabst,
  • Albert Wölfler,
  • Armin Zebisch,
  • Andrea Berghold,
  • Konstanze Döhner,
  • Heinz Sill

DOI
https://doi.org/10.3324/haematol.2018.205013
Journal volume & issue
Vol. 104, no. 3

Abstract

Read online

The role of subclonal TP53 mutations, defined by a variant allele frequency of 40%, 20%-40% and 40%, 19 had variant allele frequencies between 20%-40% and 18 had frequencies